Resources
H.R. 1965, “Patient Protection and Innovative Biologic Medicines Act of 2007”
110TH CONGRESS 1ST SESSION H. R. 1956 To amend the Public Health Service Act to provide for the approval of similar biological products, and for other purposes. IN THE HOUSE OF REPRESENTATIVES APRIL 19, 2007
H.R. Hearing on Safe and Affordable Biotech Drugs: The Need for a Generic Pathway
SAFE AND AFFORDABLE BIOTECH DRUGS: THE NEED FOR A GENERIC PATHWAY HEARING BEFORE THE COMMITTEE ON OVERSIGHT AND GOVERNMENT REFORM HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS FIRST SESSION MARCH 26, 2007 Serial No. 110–43
H.R. Hearing on Challenges and Solutions to Health Insurance Coverage for Small Businesses
FULL COMMITTEE HEARING ON CHALLENGES AND SOLUTIONS TO HEALTH INSURANCE COVERAGE FOR SMALL BUSINESSES COMMITTEE ON SMALL BUSINESS UNITED STATES HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS FIRST SESSION MARCH 14, 2007
Senate Committee Hearing 110-375, Examining FDA Follow-On Biologics
HEARING OF THE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS UNITED STATES SENATE ONE HUNDRED TENTH CONGRESS FIRST SESSION ON EXAMINING FOOD AND DRUG ADMINISTRATION FOLLOW-ON BIOLOGICS, GENERALLY REFERRED TO AS A BIOTECHNOLOGY-DERIVED PROTEIN DRUG (OR BIOLOGIC) THAT IS COMPARABLE TO A NOVEL, PREVIOUSLY APPROVED BIOLOGIC AND THAT IS APPROVED